Related Experiment Video
Updated: Jun 8, 2026

Th17 Inflammation Model of Oropharyngeal Candidiasis in Immunodeficient Mice
Published on: February 18, 2015
Candida tropicalis in human disease
Louis Yi Ann Chai1, David W Denning, Peter Warn
1Department of Medicine, National University Hospital, Singapore.
Abstract:
Candida tropicalis is one of the more common Candida causing human disease in tropical countries; the frequency of invasive disease varies by geography causing 3--66% of candidaemia. C. tropicalis is taxonomically close to C. albicans and shares many pathogenic traits. C. tropicalis is particularly virulent in neutropenic hosts commonly with hematogenous seeding to peripheral organs. For candidaemia and invasive candidiasis amphotericin B or an echinocandin are recommended as first-line treatment, with extended-spectrum triazoles acceptable alternatives. Primary fluconazole resistance is uncommon but may be induced on exposure. Physicians in regions where C. tropicalis is common need to be mindful of this lesser-described pathogen.
Insights
Candida tropicalis causes significant human disease, especially in tropical regions. Awareness and appropriate treatment are crucial due to its virulence and potential for antifungal resistance.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Tropical Medicine
Background:
- Candida tropicalis is a frequent cause of human candidiasis, particularly in tropical climates.
- It shares virulence factors with Candida albicans and poses a significant threat to immunocompromised individuals, especially those who are neutropenic.
- The incidence of invasive disease caused by C. tropicalis varies geographically, contributing between 3% and 66% of candidemia cases.
Purpose of the Study:
- To highlight the clinical significance and pathogenic traits of Candida tropicalis.
- To inform healthcare professionals about treatment options and the potential for antifungal resistance.
- To increase awareness of this pathogen in regions where it is prevalent.
Main Methods:
- Literature review and synthesis of existing data on Candida tropicalis epidemiology, pathogenicity, and treatment.
- Analysis of geographic variations in candidemia caused by C. tropicalis.
- Review of current treatment guidelines and antifungal susceptibility patterns.
Main Results:
- Candida tropicalis demonstrates significant virulence, particularly in neutropenic patients, often leading to hematogenous spread to peripheral organs.
- First-line treatments for candidemia and invasive candidiasis include amphotericin B or echinocandins, with extended-spectrum triazoles as alternatives.
- While primary fluconazole resistance is rare, it can be induced upon exposure.
Conclusions:
- Physicians in endemic areas must be vigilant regarding Candida tropicalis infections.
- Understanding the pathogen's characteristics and resistance patterns is vital for effective patient management.
- Further research may be needed to fully elucidate the geographic and clinical impact of C. tropicalis.
Related Concept Videos
Candidiasis
American Trypanosomiasis
Trichomoniasis
Fungal Phylum Microsporidia
Cryptococcal Meningitis
Toxoplasmosis

